D-Index & Metrics Best Publications
Fritz H. Schröder

Fritz H. Schröder

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 116 Citations 49,640 548 World Ranking 1870 National Ranking 58

Research.com Recognitions

Awards & Achievements

2012 - Member of the National Academy of Medicine (NAM)

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Cancer
  • Prostate cancer

His main research concerns Prostate cancer, Internal medicine, Prostate-specific antigen, Gynecology and Prostate. The Prostate cancer study combines topics in areas such as Randomized controlled trial, Surgery and Urology. The various areas that Fritz H. Schröder examines in his Internal medicine study include Endocrinology and Oncology.

His research in Prostate-specific antigen intersects with topics in Prostate biopsy, Nephrology and Antiandrogen. In Gynecology, he works on issues like Quality of life, which are connected to Anxiety. His work deals with themes such as Biopsy, Pathology and Metastasis, which intersect with Prostate.

His most cited work include:

  • Screening and Prostate-Cancer Mortality in a Randomized European Study (3160 citations)
  • Prostate-Cancer Mortality at 11 Years of Follow-up (964 citations)
  • Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer. (907 citations)

What are the main themes of his work throughout his whole career to date?

Prostate cancer, Internal medicine, Oncology, Prostate and Prostate-specific antigen are his primary areas of study. The concepts of his Prostate cancer study are interwoven with issues in Gynecology, Randomized controlled trial and Urology. His Internal medicine research incorporates themes from Endocrinology and Surgery.

His work carried out in the field of Oncology brings together such families of science as Stage, Clinical trial, PCA3 and Endocrine system. His Prostate study incorporates themes from Adenocarcinoma and Biopsy, Pathology. His studies deal with areas such as Prostate biopsy, Nephrology and Cancer screening as well as Prostate-specific antigen.

He most often published in these fields:

  • Prostate cancer (67.63%)
  • Internal medicine (57.23%)
  • Oncology (36.85%)

What were the highlights of his more recent work (between 2008-2020)?

  • Prostate cancer (67.63%)
  • Internal medicine (57.23%)
  • Oncology (36.85%)

In recent papers he was focusing on the following fields of study:

Fritz H. Schröder mainly investigates Prostate cancer, Internal medicine, Oncology, Prostate-specific antigen and Gynecology. Fritz H. Schröder interconnects Prostate, Randomized controlled trial and Urology in the investigation of issues within Prostate cancer. His research brings together the fields of Surgery and Internal medicine.

His Oncology research includes themes of Androgen deprivation therapy, Clinical trial and Metastasis. His Prostate-specific antigen study combines topics from a wide range of disciplines, such as Prostate biopsy, Cohort study, Cancer screening and PCA3. He usually deals with Gynecology and limits it to topics linked to Confidence interval and Cause of death.

Between 2008 and 2020, his most popular works were:

  • Screening and Prostate-Cancer Mortality in a Randomized European Study (3160 citations)
  • Prostate-Cancer Mortality at 11 Years of Follow-up (964 citations)
  • Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up (887 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Cancer
  • Prostate cancer

His primary areas of study are Prostate cancer, Internal medicine, Prostate-specific antigen, Oncology and Gynecology. His Prostate cancer research integrates issues from Biopsy, Prostate and Randomized controlled trial. His Internal medicine course of study focuses on Surgery and Hazard ratio and Watchful waiting.

His Prostate-specific antigen research is multidisciplinary, relying on both Psychiatry, Cohort study and Urology. His biological study spans a wide range of topics, including Prostatectomy, Metastasis, Clinical trial and Radiation therapy. His Gynecology research incorporates elements of Stage, Predictive value of tests, Cumulative incidence and Mass screening.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Screening and Prostate-Cancer Mortality in a Randomized European Study

Fritz H. Schröder;Jonas Hugosson;Monique J. Roobol;Stefano Ciatto.
The New England Journal of Medicine (2009)

4796 Citations

Prostate-Cancer Mortality at 11 Years of Follow-up

Fritz H. Schröder;Jonas Hugosson;Monique J. Roobol;Stefano Ciatto.
The New England Journal of Medicine (2012)

1570 Citations

Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up

Fritz H Schröder;Jonas Hugosson;Monique J Roobol;Teuvo L J Tammela.
The Lancet (2014)

1411 Citations

Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer.

Gerrit Draisma;Rob Boer;Suzie J. Otto;Ingrid W. van der Cruijsen.
Journal of the National Cancer Institute (2003)

1295 Citations

Maximum androgen blockade in advanced prostate cancer: an overview of the randomised trials

O Dalesio;H van Tinteren;M Clarke;R Peto.
The Lancet (2000)

1015 Citations

The efficacy and safety of degarelix: a 12‐month, comparative, randomized, open‐label, parallel‐group phase III study in patients with prostate cancer

Laurence Klotz;Laurent Boccon-Gibod;Neal D. Shore;Cal Andreou.
BJUI (2008)

607 Citations

Prospective Study of Diagnostic Accuracy Comparing Prostate Cancer Detection by Transrectal Ultrasound–Guided Biopsy Versus Magnetic Resonance (MR) Imaging with Subsequent MR-guided Biopsy in Men Without Previous Prostate Biopsies

Morgan R. Pokorny;Maarten de Rooij;Earl Duncan;Fritz H. Schröder.
European Urology (2014)

553 Citations

Active Surveillance for Low-Risk Prostate Cancer Worldwide: The PRIAS Study

Meelan Bul;Xiaoye Zhu;Riccardo Valdagni;Tom Pickles.
European Urology (2013)

539 Citations

The TNM classification of prostate cancer

F H Schröder;P Hermanek;L Denis;W R Fair.
The Prostate (1992)

536 Citations

A Prospective European Organization for Research and Treatment of Cancer Genitourinary Group Randomized Trial Comparing Transurethral Resection Followed by a Single Intravesical Instillation of Epirubicin or Water in Single Stage Ta, T1 Papillary Carcinoma of the Bladder

Willem Oosterlinck;Karl Heinz Kurth;Fritz Schröder;Jozef Bultinck.
The Journal of Urology (1993)

470 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Fritz H. Schröder

Monique J. Roobol

Monique J. Roobol

Erasmus MC

Publications: 177

Hans Lilja

Hans Lilja

Memorial Sloan Kettering Cancer Center

Publications: 166

Peter R. Carroll

Peter R. Carroll

University of California, San Francisco

Publications: 148

Francesco Montorsi

Francesco Montorsi

Vita-Salute San Raffaele University

Publications: 138

Freddie C. Hamdy

Freddie C. Hamdy

University of Oxford

Publications: 134

Jonathan I. Epstein

Jonathan I. Epstein

Johns Hopkins University

Publications: 128

Andrew J. Vickers

Andrew J. Vickers

Memorial Sloan Kettering Cancer Center

Publications: 127

Peter T. Scardino

Peter T. Scardino

Memorial Sloan Kettering Cancer Center

Publications: 124

Alberto Briganti

Alberto Briganti

Vita-Salute San Raffaele University

Publications: 123

David E. Neal

David E. Neal

University of Cambridge

Publications: 122

Alan W. Partin

Alan W. Partin

Johns Hopkins University School of Medicine

Publications: 119

Markus Graefen

Markus Graefen

Universität Hamburg

Publications: 118

Stephen J. Freedland

Stephen J. Freedland

Cedars-Sinai Medical Center

Publications: 118

Ian M. Thompson

Ian M. Thompson

The University of Texas Health Science Center at San Antonio

Publications: 116

Mark Emberton

Mark Emberton

University College London

Publications: 113

Laurence Klotz

Laurence Klotz

Sunnybrook Health Science Centre

Publications: 112

Trending Scientists

Ali Saberi

Ali Saberi

Washington State University

Changxing Miao

Changxing Miao

Institute of Applied Physics and Computational Mathematics

Corina S. Pasareanu

Corina S. Pasareanu

Carnegie Mellon University

Yuanming Lai

Yuanming Lai

Chinese Academy of Sciences

Paloma Melgarejo

Paloma Melgarejo

Ministry of Agriculture, Livestock, and Food Supply

Rajbir S. Sangwan

Rajbir S. Sangwan

University of Picardie Jules Verne

Robert P. Adams

Robert P. Adams

Baylor University

Peter R. Vogt

Peter R. Vogt

United States Naval Research Laboratory

Thomas H. Nash

Thomas H. Nash

Arizona State University

J. Paul Bolam

J. Paul Bolam

University of Oxford

James T. Enns

James T. Enns

University of British Columbia

Xiaoqin Wang

Xiaoqin Wang

Johns Hopkins University School of Medicine

Anthony F. Bogaert

Anthony F. Bogaert

Brock University

Filippo Muratori

Filippo Muratori

University of Pisa

Robert Terkeltaub

Robert Terkeltaub

University of California, San Diego

Laurent Jorda

Laurent Jorda

Aix-Marseille University

Something went wrong. Please try again later.